Some mutations are linked to an inverse outcome; for example, mutations of Tp53, IDH1/2, and SRSF2 confer an increased risk of leukemia evolution and mutations of ASXL1, EZH2, and SFSR2 are linked to shorter overall survival (OS) [14,51,52]. Here, TP53 is linked to leukemia.